Evolution Wealth Advisors’s Pacific Biosciences PACB Stock Holding History

Evolution Wealth Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84K	Hold	50,000	–	–	0.01%	179
2026 Q1	$66K	Hold	50,000	–	–	0.01%	174
2025 Q4	$93.5K	Hold	50,000	–	–	0.01%	163
2025 Q3	$64K	Hold	50,000	–	–	0.01%	163
2025 Q2	$62K	Hold	50,000	–	–	0.01%	167
2025 Q1	$59K	Hold	50,000	–	–	0.01%	146
2024 Q4	$91.5K	Hold	50,000	–	–	0.02%	141
2024 Q3	$85K	Hold	50,000	–	–	0.02%	132
2024 Q2	$68K	Hold	50,000	–	–	0.01%	130
2024 Q1	$188K	Hold	50,000	–	–	0.04%	127
2023 Q4	$491K	Hold	50,000	–	–	0.1%	80
2023 Q3	$418K	Hold	50,000	–	–	0.09%	82
2023 Q2	$665K	Hold	50,000	–	–	0.15%	63
2023 Q1	$579K	Hold	50,000	–	–	0.14%	60
2022 Q4	$409K	Hold	50,000	–	–	0.1%	83
2022 Q3	$290K	Hold	50,000	–	–	0.08%	90
2022 Q2	$221K	Hold	50,000	–	–	0.06%	97
2022 Q1	$455K	Hold	50,000	–	–	0.09%	74
2021 Q4	$1.02M	Hold	50,000	–	–	0.15%	51
2021 Q3	$1.28M	Hold	50,000	–	–	0.27%	40
2021 Q2	$1.75M	Hold	50,000	–	–	0.36%	47
2021 Q1	$1.67M	Buy	+50,000	New	+$1.75M	0.37%	48

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Evolution Wealth Advisors's PACB Position: Q2 2026 in Review

Evolution Wealth Advisors held its Pacific Biosciences (PACB) position steady in Q2 2026 at 50,000 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #179.

Evolution Wealth Advisors first reported a position in PACB in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.75M in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Evolution Wealth Advisors held 50,000 shares of Pacific Biosciences worth $84K as of Q2 2026.
Evolution Wealth Advisors left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up 0.01% of Evolution Wealth Advisors's portfolio in Q2 2026, its #179 holding.
Evolution Wealth Advisors first reported a position in Pacific Biosciences in Q1 2021 and has held it in 22 quarters since.
Evolution Wealth Advisors's Pacific Biosciences position peaked at $1.75M in Q2 2021.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Evolution Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.